Feeling stressed or down in a world with COVID? Try this writing tool

A new tool uses expressive writing to help cancer patients, others cope with life challenges during the coronavirus pandemic
Michigan Medicine - University of Michigan

Newswise — ANN ARBOR, Michigan — Living with a cancer diagnosis – whether your own or a loved one's – is difficult under the best circumstances. Living with it during a pandemic adds a whole new layer of challenge. 

A new tool that gets people writing could help provide calming relief. 

The University of Michigan Rogel Cancer Center created a new expressive writing tool called Making Meaning that allows people to put their thoughts and feelings into words to help relieve stress and anxiety. 

“Many people with cancer, while they receive excellent physical treatment, have unmet needs around their emotional care. Making Meaning is a simple way for people to express themselves and gain a sense of control and agency over these challenges,” says Lawrence An, M.D., co-director of the Center for Health Communications Research at the Rogel Cancer Center. 

While the tool was conceived to help people with cancer, anyone can participate by choosing one of three writing prompts:

  • What are your thoughts and feelings about your life right now?
  • Find the positive
  • What are your thoughts and feelings about the coronavirus crisis and cancer care? 

Participants are directed to write for 5-10 minutes, expressing their deepest thoughts and feelings about the topic – without regard to spelling, grammar or sentence structure. The idea is just to write. 

The whole process is anonymous and private. Submissions are analyzed by a computer using natural language processing to provide feedback based on keywords and tone. No person reads the submissions and you’re never asked to provide contact information. The site includes additional coping resources for further follow-up. 

Hundreds of studies have shown expressive writing can help reduce stress, improve sleep, improve mental health and potentially even boost the immune system. An and team partnered with James Pennebaker, Ph.D., professor of psychology at the University of Texas at Austin, who published the first article on expressive writing in 1986. 

“One of the nice things about expressive writing is it’s simple and something you can do on your own. It’s a method that has a good track record and is worth trying out,” Pennebaker says.

Visit the Making Meaning website at http://michmed.org/kvLao.

 




Filters close

Showing results

110 of 4156
Newswise: Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
23-Nov-2020 5:20 PM EST
Stimulus Relief Funds Increase Social Distancing to Stop Spread of COVID-19
University of California San Diego

As case rates of COVID-19 reach new heights across the nation, many states and cities are tightening stay-at-home restrictions to stop the spread. New research suggests that that those suffering from economic hardships are less likely comply with new stay-at-home orders; however these same U.S. residents would be more likely to adhere to the new public health guidelines if their households received stimulus funds.

access_time Embargo lifts in 2 days
Embargo will expire: 1-Dec-2020 9:15 AM EST Released to reporters: 30-Nov-2020 2:30 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 1-Dec-2020 9:15 AM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise:Video Embedded covid-19-update-surge-preparedness-vaccine-distribution
VIDEO
Released: 30-Nov-2020 2:20 PM EST
COVID-19 Update: Surge Preparedness, Vaccine Distribution
Cedars-Sinai

With the novel coronavirus spreading across the U.S. at a record pace, Cedars-Sinai has been seeing an increase in COVID-19 patients at its hospitals and through its network of physicians. But the health system's leaders say Cedars-Sinai is prepared.

Released: 30-Nov-2020 1:20 PM EST
Rethink COVID-19 infection control to keep primary schools open this winter, governments urged
BMJ

An urgent rethink of infection control policies to keep COVID-19 infection at bay in schools is needed if primary schools are to be kept open this winter, and the knock-on effects on their families avoided, argue children's infectious disease specialists in a viewpoint, published online in the Archives of Disease in Childhood.

Newswise: Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Released: 30-Nov-2020 12:45 PM EST
Hackensack University Medical Center Urologists Continue to Provide State-of-the-Art Care During COVID-19
Hackensack Meridian Health

Don’t Delay Your Care – Our dnhanced pandemic safety precautions prioritize patient health and allow providers to deliver outstanding in-office, telehealth and surgical care

Released: 30-Nov-2020 12:10 PM EST
Struggles of care home staff during COVID-19 first wave revealed in Whatsapp messages
University of Leeds

Analysis of social media messages between care home staff on the coronavirus front line reveal their growing concerns over how to manage in the face of the virus.

Released: 30-Nov-2020 11:30 AM EST
More than one-third of children with COVID-19 show no symptoms: study
University of Alberta Faculty of Medicine & Dentistry

More than one-third of kids who have COVID-19 are asymptomatic, according to a University of Alberta study that suggests youngsters diagnosed with the disease may represent just a fraction of those infected.

Newswise: Promising lab results in quest to find naturally occurring anti-COVID therapies
24-Nov-2020 5:35 PM EST
Promising lab results in quest to find naturally occurring anti-COVID therapies
University of Alabama Huntsville

So far, 35 of 125 naturally occurring compounds identified computationally at The University of Alabama in Huntsville (UAH) to have potential against COVID-19 have shown efficacy in ongoing first-batch testing at the University of Tennessee Health Science Center’s Regional Biocontainment Laboratory (UTHSC RBL) that’s the next step in the process to becoming a drug.

Released: 30-Nov-2020 9:45 AM EST
Rutgers Leading Coronavirus Therapeutic Clinical Trial
Rutgers University-New Brunswick

Rutgers is leading a clinical trial assessing the efficacy of a three-drug combination in treating people infected with SARS-CoV-2 and asymptomatic or mildly symptomatic.


Showing results

110 of 4156

close
1.40077